Syngene International Ltd.
Snapshot View

View in App

Prices View details >>

578.85 +1.55 ▲0.3%

29 March 2023, 04:01:00 PM
Volume: 14,916

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.syngeneintl.com
Market Cap 23,237.04 Cr.
Enterprise Value(EV) 23,731.64 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 10.80 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 53.62 Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 84.29 Trailing Twelve Months Ending 2022-12
Price to Book Value 6.87 Calculated using Price: 578.85
Dividend Yield 0.17 Period Ending 2022-03
No. of Shares Subscribed 40.14 Cr. 401,434,500 Shares
FaceValue 10
Company Profile
The company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies worldwide. Services offered by the company are Discovery Chemistry, Discovery Biology, Safety Assessment, Large Molecule Development, Chemical Development, Formulation Development, Stability Studies, Polymer Research, Integrated Discovery & Development, Clinical Development Services, Bioinformatics, Antibody Drug Conjugates, Oligonucleotide Synthesis.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.27%
1 Week
+0.23%
1 Month
-0.28%
3 Month
+0.29%
6 Month
+3.93%
1 Year
-0.91%
2 Year
+8.31%
5 Year
+96.62%
10 Year

Ratios View Details >>

5 years 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.05 18.26 20.21 16.59 13.29
Return on Capital Employed (%) 15.76 16.98 19.60 15.40 13.24
Return on Assets (%) 9.80 9.86 10.77 9.17 7.69

Balance Sheet View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1,720 1,968 2,176 2,821 3,298 3,274
Non Curr. Liab. 613 515 325 840 972 968
Curr. Liab. 784 1,129 1,539 1,133 1,229 1,035
Minority Int.
Equity & Liab. 3,117 3,612 4,040 4,794 5,498 5,277
Non Curr. Assets 1,396 1,848 2,428 2,987 3,292 3,275
Curr. Assets 1,720 1,764 1,613 1,807 2,206 2,002
Misc. Exp. not W/O
Total Assets 3,117 3,612 4,040 4,794 5,498 5,277

Profit Loss View Details >>

Particulars 6 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,423 1,826 2,012 2,184 2,604 2,957
Other Income 136 76 96 83 108 72
Total Income 1,559 1,902 2,108 2,268 2,713 3,029
Total Expenditure -1,033 -1,290 -1,409 -1,531 -1,864 -2,095
PBIDT 527 612 700 736 849 933
Interest -23 -32 -35 -28 -24 -40
Depreciation -131 -164 -219 -275 -310 -351
Taxation -67 -84 -105 -64 -89 -108
Exceptional Items 71 35 -31
PAT 305 332 412 405 396 433
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 305 332 412 405 396 433
Adjusted EPS 8 8 10 10 10 11

Cash Flow View Details >>

Particulars 5 years 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 446 630 677 701 581
Cash Fr. Inv. -349 -647 -428 -628 -612
Cash Fr. Finan. -79 -72 -226 58 -31
Net Change 18 -89 23 131 -62
Cash & Cash Eqvt 253 165 193 323 262

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 70.59 70.58 70.43 70.42 70.41 70.41 70.29 64.86 64.86
Public 29.41 29.42 29.57 29.58 29.59 29.59 29.71 35.14 35.14
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 29 Mar 2023
Closure of Trading Window
This is to inform you that pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and Companys Code of Conduct for Prevention of Insider Trading & Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information the Trading Window of the Company for dealing in securities of the Company will be closed from April 01 2023 until 48 (Forty-Eight) hours after the declaration of financial results of the Company for the 4th quarter and financial year ended March 31 2023.
Sat, 25 Mar 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation to our letter dated March 24 2023 regarding Notice of Postal Ballot we hereby enclose the copies of newspaper advertisements published in the Financial Express (English language- All India Edition) and Vijayavani (Kannada- Bengaluru Edition) on March 25 2023.
Fri, 24 Mar 2023
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
We hereby submit a copy of the Postal Ballot Notice of Syngene International Limited along with the Explanatory Statement for seeking approval of the Members of the Company on the Special Resolutions forming part of the Notice.

Technical Scans View Details >>

Wed, 29 Mar 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Opening at Low Opening at Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.37 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.66 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.90 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 7.53 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.77 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Syngene International Ltd.

What is Syngene Internation. share price?
Can I buy Syngene Internation. shares now?
What is the Dividend Yield of Syngene Internation.?
What is the Market Cap of Syngene Internation.?
What are the key metrics to analyse Syngene Internation.?
What is the 52 Week High and Low of Syngene Internation.?
What is the trend of Syngene Internation. share price?